Ex parte PERSHADSINGH et al. - Page 7




                   Appeal No. 95-0885                                                                                                                                  
                   Application 07/725,327                                                                                                                              


                   we  agree with  the  examiner  that  Hindley  teaches  closely  related  compounds  possessing  the                                                 
                   thiazolidine moiety as claimed by appellants.                                                                                                       
                             The examiner concluded that the compounds recited in claim 1 would have been obvious over                                                 
                   Hindley because the patentee discloses thiazolidine derivatives that can be used to treat hypertension.                                             
                   Appellants’ principal argument is that Hindley’s hypertension is not essential hypertension as required                                             
                   by the claims on appeal.  Appellants contend that those skilled in the art would have recognized that                                               
                   hypertension is not synonymous with essential hypertension, that there is no reasonable expectation                                                 
                   that thiazolidines would be useful to treat essential hypertension, and that, at best, Hindley provides                                             
                   an invitation to experiment.  Appellants argue that “where Hindley refers to ‘hyperlipidemia,                                                       
                   hypertension, cardiovascular disease, and certain eating disorders’ one of ordinary skill would                                                     
                   understand this to be a suggestion that treatment of diabetes with thiazolidines may also be useful to                                              
                   ameliorate the signs and symptoms that are secondary to the diabetes” (brief, p. 9).  Appellants rely                                               
                   on declarations by Dr. Kurtz, M.D. (hereinafter the Kutrz I declaration ), one of the named inventors,4                                                           

                   and a declaration by Dr. Mark, M.D. (the Mark declaration) to support their arguments.                                                              
                             Both the Mark and Kurtz I declarations state that “[e]ssential hypertension is a specifically                                             
                   diagnosed clinical disorder and hypertension is a ‘sign’ [symptom] of many other clinical disorders”                                                
                   (Mark declaration, ¶6(a) and Kurtz I declaration, ¶5(a)).  Appellants define essential hypertension                                                 


                             4Two declarations were submitted by Dr. Kurtz during prosection.  One declaration (the Kurtz I declaration)                               
                   was submitted on July 2, 1993 and assigned Paper No. 14.  The  other declaration (the Kurtz II declaration) was                                     
                   submitted on November 23, 1993 and assigned Paper No. 18.  The Kurtz II declaration is not relevant to our decision                                 
                   here since it is directed to an interpretation of the Kotchen, Meehan and Fujiwara references which are not before us.                              
                                                                                 -7-                                                                                   





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007